Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodies. - Thran M; Pönisch M; Danz H; Horscroft N; Ichtchenko K; Tzipori S; Shoemaker CB (Scientific reports, 2023)